Rationale for the milvexian dosing in the phase 3 LIBREXIA program. Weitz JI, Harrington RA. J Thromb Haemost 2026;24:2158-2169.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Weitz JI, Harrington RA. Rationale for the milvexian dosing in the phase 3 LIBREXIA program. J Thromb Haemost 2026;24:2158-2169.
PMID: 41791675